$522 Million is the total value of SABBY MANAGEMENT, LLC's 106 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | KANDI TECHNOLOGIES GROUP INCput | $7,040,000 | – | 10,203 | +100.0% | 1.35% | – | |
New | ZOOM VIDEO COMMUNICATIONSput | $6,746,000 | – | 200 | +100.0% | 1.29% | – | |
New | PENN NATL GAMING INCput | $6,314,000 | – | 731 | +100.0% | 1.21% | – | |
New | PELOTON INTERACTIVE INCput | $4,551,000 | – | 300 | +100.0% | 0.87% | – | |
New | SORRENTO THERAPEUTICS INCcall | $4,274,000 | – | 6,262 | +100.0% | 0.82% | – | |
New | TRILLIUM THERAPEUTICS INCput | $3,500,000 | – | 2,379 | +100.0% | 0.67% | – | |
New | MIRATI THERAPEUTICS INCcall | $3,185,000 | – | 145 | +100.0% | 0.61% | – | |
RVPH | New | REVIVA PHARMACEURICALS | $3,133,000 | – | 358,300 | +100.0% | 0.60% | – |
New | TRILLIUM THERAPEUTICS INC | $1,765,000 | – | 119,996 | +100.0% | 0.34% | – | |
GLBS | New | GLOBUS MARITIME LTD | $1,659,000 | – | 290,535 | +100.0% | 0.32% | – |
TCDA | New | TRICIDA INC | $1,413,000 | – | 200,437 | +100.0% | 0.27% | – |
New | MARINUS PHARMACEUTICALS INC | $1,230,000 | – | 100,800 | +100.0% | 0.24% | – | |
ASTC | New | ASTROTECH CORP | $1,123,000 | – | 634,297 | +100.0% | 0.22% | – |
New | AURINIA PHARMACEUTICALS INCput | $1,047,000 | – | 757 | +100.0% | 0.20% | – | |
HMCOU | New | HUMANCO ACQUISITION CORPunit | $1,047,000 | – | 95,050 | +100.0% | 0.20% | – |
CLRB | New | CELLECTAR BIOSCIENCES | $1,038,000 | – | 499,030 | +100.0% | 0.20% | – |
New | ACTINIUM PHARMACEUTICALS INCcall | $1,020,000 | – | 1,308 | +100.0% | 0.20% | – | |
KNDI | New | KANDI TECHNOLOGIES GROUP INC | $729,000 | – | 105,714 | +100.0% | 0.14% | – |
MRTX | New | MIRATI THERAPEUTICS INC | $659,000 | – | 3,000 | +100.0% | 0.13% | – |
New | NABRIVA THERAPEUTICS PLC | $629,000 | – | 260,000 | +100.0% | 0.12% | – | |
New | CBAK ENERGYput | $629,000 | – | 2,938 | +100.0% | 0.12% | – | |
New | BELLICUM PHARMACEUTICALS INC | $563,000 | – | 159,500 | +100.0% | 0.11% | – | |
CTRM | New | CASTOR MARITIME INC | $527,000 | – | 2,850,634 | +100.0% | 0.10% | – |
New | BIOHAVEN PHARMACEUTICAL HLDGcall | $454,000 | – | 53 | +100.0% | 0.09% | – | |
NAOV | New | NANOVIBRONIX INC | $446,000 | – | 583,415 | +100.0% | 0.08% | – |
New | ORAMED PHARMACEUTICALS INCput | $420,000 | – | 991 | +100.0% | 0.08% | – | |
ALNA | New | ALLENA PHARMACEUTICALS INC | $345,000 | – | 269,836 | +100.0% | 0.07% | – |
AMBO | New | AMBOW EDUCATION HOLDING LTDads | $329,000 | – | 151,772 | +100.0% | 0.06% | – |
New | INTRA-CELLULAR THERAPIEScall | $318,000 | – | 100 | +100.0% | 0.06% | – | |
LIXTW | New | LIXTE BIOTECHNOLOGY HLDGS INC*w | $306,000 | – | 339,542 | +100.0% | 0.06% | – |
New | ACTINIUM PHARMACEUTICALS INCput | $297,000 | – | 381 | +100.0% | 0.06% | – | |
RWLK | New | REWALK ROBOTICS LTD | $254,000 | – | 192,382 | +100.0% | 0.05% | – |
ATHE | New | ALTERITY THERAPEUTICS LTDadr | $249,000 | – | 185,843 | +100.0% | 0.05% | – |
New | SPI ENERGY CO LTDput | $238,000 | – | 302 | +100.0% | 0.05% | – | |
New | CATABASIS | $231,000 | – | 108,026 | +100.0% | 0.04% | – | |
CYTHW | New | CYCLO THERAPEUTICS INC*w | $208,000 | – | 193,012 | +100.0% | 0.04% | – |
New | BIOCEPT INCput | $211,000 | – | 476 | +100.0% | 0.04% | – | |
BMYRT | New | BRISTOL MYERS SQUIBB | $207,000 | – | 300,000 | +100.0% | 0.04% | – |
PTE | New | POLARITYTE INC | $163,000 | – | 239,200 | +100.0% | 0.03% | – |
BIOC | New | BIOCEPT INC | $140,000 | – | 31,578 | +100.0% | 0.03% | – |
New | INOVIO PHARMACEUTICALScall | $114,000 | – | 129 | +100.0% | 0.02% | – | |
MICT | New | MICT INC | $111,000 | – | 53,559 | +100.0% | 0.02% | – |
New | ARCADIA BIOSCIENCES INCput | $61,000 | – | 242 | +100.0% | 0.01% | – | |
NTEC | New | INTEC PHARMA LTD | $35,000 | – | 10,199 | +100.0% | 0.01% | – |
New | NABRIVA THERAPEUTICS PLCput | $29,000 | – | 120 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
SPDR S&P 500 ETF TRUST UNIT | 37 | Q3 2023 | 49.1% |
ISHARES TR | 35 | Q3 2023 | 52.2% |
SPDR S&P BIOTECHNOLOGY | 32 | Q3 2022 | 12.8% |
AMARIN CORP PLC | 30 | Q4 2021 | 2.0% |
BIOGEN INC | 24 | Q1 2021 | 26.2% |
SAREPTA THERAPEUTICS INC | 24 | Q3 2020 | 4.6% |
BIOGEN INC | 23 | Q1 2021 | 13.7% |
SAREPTA THERAPEUTICS INC | 22 | Q3 2020 | 6.2% |
BRAINSTORM CELL THERAPEUTICS INC | 21 | Q3 2023 | 1.6% |
VERTEX PHARMACEUTICALS INC | 20 | Q1 2018 | 12.6% |
View SABBY MANAGEMENT, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AGM GROUP HOLDINGS, INC. | January 10, 2023 | 627,936 | 2.6% |
Bit Digital, Inc | January 10, 2023 | 3,166,917 | 3.8% |
Cingulate Inc. | January 10, 2023 | 10 | 5.0% |
Context Therapeutics Inc. | January 10, 2023 | 796,706 | 5.0% |
HeartBeam, Inc. | January 10, 2023 | 271,788 | 3.4% |
PharmaCyte Biotech, Inc. | January 10, 2023 | 934,456 | 5.0% |
Rebus Holdings, Inc.Sold out | January 10, 2023 | 0 | 0.0% |
TANTECH HOLDINGS LTD | January 10, 2023 | 41,500 | 0.6% |
Quanergy Systems, Inc. | January 04, 2023 | 936,905 | 5.8% |
TuanChe Ltd | January 04, 2023 | 2,384,713 | 10.0% |
View SABBY MANAGEMENT, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-14 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-04 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
SC 13G | 2024-01-03 |
View SABBY MANAGEMENT, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.